Crossref
CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US
JAMA · 2024
DOI: 10.1001/jama.2024.11024 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Doxycycline, Sexually Transmitted Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Anti-Bacterial AgentsDoxycyclineSexually Transmitted DiseasesFemaleHumansMaleAntibiotic ProphylaxisCenters for Disease Control and Prevention, U.S.GonorrheaPractice Guidelines as TopicUnited StatesSexual and Gender MinoritiesTransgender Persons
Substanzen
Anti-Bacterial AgentsDoxycycline
Zitieren
APA
Harris, E. (2024). CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US. JAMA. https://doi.org/10.1001/jama.2024.11024
Vancouver
Harris E. CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US. JAMA. 2024. doi:10.1001/jama.2024.11024
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.11024}
}
EUVIMED